相关实验视频
Updated: Jul 13, 2026

08:28
Monitoring the Wall Mechanics During Stent Deployment in a Vessel
Published on: May 8, 2012
9.2K
冠状动脉支架扩张下的管理
Primero Ng1, Akiko Maehara2, Ajay J Kirtane2
1Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA.
Journal of the American College of Cardiology
|February 12, 2025
概括
冠状动脉支架不充分扩张是穿皮冠状动脉干预的并发症,增加了心脏病发作和死亡的风险. 这篇综述详细介绍了病因,诸如血管内成像等诊断工具,以及改善患者治疗结果的策略.
科学领域:
- 心血管干预 心血管干预
- 干预心脏病学 干预心脏病学
- 医疗器械技术 医疗器械技术
背景情况:
- 冠状动脉支架不充分扩张是皮肤穿冠状动脉干预 (PCI) 的一个显著限制.
- 它导致不充分的光线增益,增加支架血栓形成,静脉缩,心肌梗塞和死亡的风险.
- 这些因素包括化,病变准备不良和低于最佳的部署.
研究的目的:
- 审查目前的证据,临床经验和冠状动脉支架扩张不足的治疗策略.
- 为优化PCI和患者结果提供实际指导.
- 为了解决因有限的前性研究而缺乏关于最佳治疗的共识.
主要方法:
- 对现有证据和临床经验进行全面的文献审查.
- 分析导致的因素和管理不充分扩张的支架的挑战.
- 评估血管内成像模式 (IVUS,OCT) 在诊断和管理中的作用.
主要成果:
- 支架不充分扩张与不良临床事件有关,包括复原和血栓形成.
- 严重的化和复杂的斑块形态为支架优化带来了挑战.
- 血管内成像对于准确的诊断和指导治疗策略至关重要.
结论:
- 由于缺乏大型前性试验,对支架不扩张的最佳治疗方法仍未确定.
- 血管内成像有助于理解机制和定制干预措施.
- 需要进一步的研究,以建立基于证据的指导方针来管理支架不扩张.
相关概念视频
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...

